Global Health Institute

The Global Health Institute of Merck KGaA, Darmstadt, Germany is mandated to improve the health of underserved populations in the developing world addressing unmet medical needs related to infectious diseases.

Global Health Institute of Merck KGaA, Darmstadt, Germany

Our vision

In line with our corporate responsibility, the Company is committed to improving the health of underserved populations, that lack access to health solutions including prevention, diagnostics and therapy.

The Institute is mandated to impact and contribute in a sustainable manner to the worldwide Global Health Agenda for the Company. 





Our goal

The Global Health Institute is working to address key unmet medical needs related to infectious diseases- such as schistosomiasis and malaria (including co-infections) as well as bacterial infections and related antimicrobial resistance.

The goal is to develop innovative and integrated health solutions (drugs, diagnostics, medical devices, vector controls and digital health tools) for the most vulnerable populations (children and women) in developing countries.


Our approach

The Global Health Institute uses an integrated approach to develop and deliver health solutions that address major global health challenges.

The approach covers:

  • Treatments for high unmet medical needs
  • Detection focusing on highly sensitive and specific diagnostic detection methods
  • Transmission controls for developing products and technologies to improve preventive measures
  • Digital health tools to strengthen health systems through technologies and education programs.

Our operating model

The Global Health Institute operates through a social business model that aims to ensure sustainability, affordability and availability of final products and services.
It consists of a non-maximizing profit model to increase impact and ensuring financial sustainability.

The model is based on public-private partnerships with leading global health institutions/organizations in both developed and developing countries.

Our portfolio

The Institute has developed a comprehensive portfolio, including the following programs:

  • Development of a pediatric Praziquantel (PZQ) formulation to treat schistosomiasis in children under the age of six
    More information 
  • Development of a new active ingredient for the treatment and prevention of malaria in very young children
  • Screening programs through dedicated drug discovery platforms for new potential candidates against schistosomiasis and malaria
  • Development of diagnostics for schistosomiasis and for malaria
  • Development of products and technologies to improve preventive measures

The Global Health portfolio showcases the company's continuous engagement in the fight against infectious diseases.  In the Access to Medicines Index, this has helped us to achieve second place in the technical area of R&D, leading to its overall fourth place ranking in the 2016 Index.


Global Health Institute of Merck KGaA, Darmstadt, Germany
More information
Global Health Institute of Merck KGaA, Darmstadt, Germany

The Institute develops integrated health solutions for children and women to address major global health challenges.

Consortium Pediatric Praziquantel Program
More information
Consortium Pediatric Praziquantel Program

The Pediatric Praziquantel Consortium is an international public-private partnership that aims to develop, register and provide access to a suitable pediatric praziquantel formulation for treating schistosomiasis in preschool-age children (below 6 years of age).

The Integrated Malaria Program
More information
The Integrated Malaria Program

Effective control of malaria requires an integrated approach. The Malaria program aims to develop treatments, diagnostics and vector control methods; it also seeks to strengthen health systems through digital health initiatives and educational programs in and for developing countries

Our Contact

The Global Health team can be contacted at:

Members of the team are also present at international conferences and events on global health/infectious diseases, with focus on schistosomiasis, malaria and bacterial infections.


You have accessed, but for users from your part of the world, we originally designed the following web presence

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement